Month: November 2018
-
Trials OK’d for Inherited Eye Disease Therapy with Crispr
The company developing a treatment for a rare inherited eye disease using the genome editing technique Crispr received authorization from the Food and Drug Administration to begin clinical trials.
-
Project to Catalog Precision Lung Cancer Immunotherapies
A new research initiative in the U.K. is collecting and mapping precise combinations of therapies that invoke the immune system to treat lung cancer.
-
Out of Action Unexpectedly – Coping with Time Off Work
Whatever your bump in the road may be, here are a few helpful ideas that might just get you through it all.
-
Nanotech Polymers Deliver More Effective Arthritis Therapy
A chemical engineering lab developed a process to help proteins combined with nanoscale polymers penetrate the cartilage in lab rodents and boost treatment for damage caused by osteoarthritis.
-
Prosthetic Joint Provides More Natural Wrist Movements
An academic-industry engineering team in Sweden developed and tested a prosthetic wrist joint that provides more natural movement and control than most current devices.
-
Achieving Health And Safety In Our Most Dangerous Industries
Health and safety in the workplace is crucial no matter which industry you’re involved in.
-
Personalized Computer Models Developed for Heart Disease
Researchers in the U.K. are developing computer models of heart functions that enable physicians to simulate recommended treatments for individual patients to gauge and optimize their outcomes.
-
Vital Signs Electronic Tag Designed to Aid First Responders
A simple electronic monitoring device that adheres to the chest aims to provide basic vital signs data to first responders and emergency medical staff in mass casualty situations.
-
Investing In Science And Tech – What You Need To Know
If you think that these are the best sectors for you to invest in right now, these following tips should help you get started.
-
Company Formed to Advance Sickle Cell Gene Therapy
A Swiss medical technologies company and Cincinnati Children’s hospital in Ohio are starting a new enterprise to commercialize research on gene therapies for inherited blood disorders.